Teva Pharma (TEVA) and Medincell Report Positive Phase 3 Efficacy Results from SOLARIS Trial Evaluating TEV-749
Go back to Teva Pharma (TEVA) and Medincell Report Positive Phase 3 Efficacy Results from SOLARIS Trial Evaluating TEV-749| TEVA PHARMACEUTICAL INDUSTRIES (NYSE: TEVA) | Delayed: 38.80 -0.39 (1%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $39.19 | 52 Week High | $66.55 | |||
| Open | $38.90 | 52 Week Low | $37.82 | |||
| Day High | $39.19 | P/E | N/A | |||
| Day Low | $38.73 | EPS | $0.00 | |||
| Volume | 1,004,783 | |||||
